Akili tests if therapeutic game could be used to treat Covid ‘brain fog’
Can technology increase COVID-19 vaccination rates?
11/04/2021
People who see people: How high mixers help spread COVID-19 | McKinsey & Company
11/04/2021
Akili Interactive received FDA clearance last year for its game-based digital therapeutic to be used as a treatment for ADHD. Now, the company is testing it to see if it could help people experiencing cognitive dysfunction after Covid-19.
Lire l’article complet sur : medcitynews.com
